{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T04:11:03Z","timestamp":1790655063301,"version":"4.1.0"},"reference-count":45,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2012,9,1]],"date-time":"2012-09-01T00:00:00Z","timestamp":1346457600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Kidney International"],"published-print":{"date-parts":[[2012,9]]},"DOI":"10.1038\/ki.2012.170","type":"journal-article","created":{"date-parts":[[2012,5,23]],"date-time":"2012-05-23T09:44:28Z","timestamp":1337766268000},"page":"643-651","source":"Crossref","is-referenced-by-count":61,"title":["Aldosterone deficiency and mineralocorticoid receptor antagonism prevent angiotensin II\u2013induced cardiac, renal, and vascular injury"],"prefix":"10.1016","volume":"82","author":[{"given":"James M.","family":"Luther","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pengcheng","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zuofei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samuel E.","family":"Cohen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyung-Suk","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agnes B.","family":"Fogo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nancy J.","family":"Brown","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1038\/ki.2012.170_bb0010","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1056\/NEJM199311113292004","article-title":"The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. The Collaborative Study Group","volume":"329","author":"Lewis","year":"1993","journal-title":"N Engl J Med"},{"key":"10.1038\/ki.2012.170_bb0015","doi-asserted-by":"crossref","first-page":"1893","DOI":"10.1056\/NEJMoa032292","article-title":"Valsartan, captopril, or both in myocardial infarction complicated by heart failure, left ventricular dysfunction, or both","volume":"349","author":"Pfeffer","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1038\/ki.2012.170_bb0020","doi-asserted-by":"crossref","first-page":"2641","DOI":"10.1681\/ASN.2009070737","article-title":"Addition of angiotensin receptor blockade or mineralocorticoid antagonism to maximal angiotensin-converting enzyme inhibition in diabetic nephropathy","volume":"20","author":"Mehdi","year":"2009","journal-title":"J Am Soc Nephrol"},{"key":"10.1038\/ki.2012.170_bb0025","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1056\/NEJMoa030207","article-title":"Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction","volume":"348","author":"Pitt","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1038\/ki.2012.170_bb0030","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1056\/NEJM199909023411001","article-title":"The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators","volume":"341","author":"Pitt","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1038\/ki.2012.170_bb0035","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1161\/01.HYP.0000203772.78696.67","article-title":"Mineralocorticoid receptor antagonism attenuates cardiac hypertrophy and failure in low-aldosterone hypertensive rats","volume":"47","author":"Nagata","year":"2006","journal-title":"Hypertension"},{"key":"10.1038\/ki.2012.170_bb0040","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1161\/01.HYP.0000222003.28517.99","article-title":"Podocyte injury underlies the glomerulopathy of Dahl salt-hypertensive rats and is reversed by aldosterone blocker","volume":"47","author":"Nagase","year":"2006","journal-title":"Hypertension"},{"key":"10.1038\/ki.2012.170_bb0045","doi-asserted-by":"crossref","first-page":"F802","DOI":"10.1152\/ajprenal.00197.2009","article-title":"Mineralocorticoid receptor blockade and calcium channel blockade have different renoprotective effects on glomerular and interstitial injury in rats","volume":"297","author":"Du","year":"2009","journal-title":"Am J Physiol Renal Physiol"},{"key":"10.1038\/ki.2012.170_bb0050","doi-asserted-by":"crossref","first-page":"3087","DOI":"10.1161\/CIRCULATIONAHA.104.521625","article-title":"Aldosterone synthase inhibitor ameliorates angiotensin II-induced organ damage","volume":"111","author":"Fiebeler","year":"2005","journal-title":"Circulation"},{"key":"10.1038\/ki.2012.170_bb0055","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1038\/ki.2009.9","article-title":"Aldosterone antagonism or synthase inhibition reduces end-organ damage induced by treatment with angiotensin and high salt","volume":"75","author":"Lea","year":"2009","journal-title":"Kidney Int"},{"key":"10.1038\/ki.2012.170_bb0060","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1161\/01.RES.0000159937.05502.d1","article-title":"Angiotensin II and aldosterone regulate gene transcription via functional mineralocortocoid receptors in human coronary artery smooth muscle cells","volume":"96","author":"Jaffe","year":"2005","journal-title":"Circ Res"},{"key":"10.1038\/ki.2012.170_bb0065","doi-asserted-by":"crossref","first-page":"2792","DOI":"10.1161\/01.CIR.0000131860.80444.AB","article-title":"Aldosterone potentiates angiotensin II-induced signaling in vascular smooth muscle cells","volume":"109","author":"Mazak","year":"2004","journal-title":"Circulation"},{"key":"10.1038\/ki.2012.170_bb0070","doi-asserted-by":"crossref","first-page":"2229","DOI":"10.1210\/en.2008-1296","article-title":"Endogenous aldosterone contributes to acute angiotensin II-stimulated plasminogen activator inhibitor-1 and preproendothelin-1 expression in heart but not aorta","volume":"150","author":"Luther","year":"2009","journal-title":"Endocrinology"},{"key":"10.1038\/ki.2012.170_bb0075","doi-asserted-by":"crossref","first-page":"F61","DOI":"10.1152\/ajprenal.00257.2005","article-title":"Kidney function in mice lacking aldosterone","volume":"290","author":"Makhanova","year":"2006","journal-title":"Am J Physiol Renal Physiol"},{"key":"10.1038\/ki.2012.170_bb0080","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1161\/01.HYP.37.2.787","article-title":"Mineralocorticoid receptor affects AP-1 and nuclear factor-kappab activation in angiotensin II-induced cardiac injury","volume":"37","author":"Fiebeler","year":"2001","journal-title":"Hypertension"},{"key":"10.1038\/ki.2012.170_bb0085","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1046\/j.1523-1755.2003.00929.x","article-title":"Aldosterone\/salt induces renal inflammation and fibrosis in hypertensive rats","volume":"63","author":"Blasi","year":"2003","journal-title":"Kidney Int"},{"key":"10.1038\/ki.2012.170_bb0090","doi-asserted-by":"crossref","first-page":"4828","DOI":"10.1210\/en.2002-220120","article-title":"Selective aldosterone blockade prevents angiotensin II\/salt-induced vascular inflammation in the rat heart","volume":"143","author":"Rocha","year":"2002","journal-title":"Endocrinology"},{"key":"10.1038\/ki.2012.170_bb0095","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1006\/jmcc.1993.1066","article-title":"Anti-aldosterone treatment and the prevention of myocardial fibrosis in primary and secondary hyperaldosteronism","volume":"25","author":"Brilla","year":"1993","journal-title":"J Mol Cell Cardiol"},{"key":"10.1038\/ki.2012.170_bb0100","doi-asserted-by":"crossref","first-page":"3153","DOI":"10.1210\/en.2004-0005","article-title":"Eplerenone, but not steroid withdrawal, reverses cardiac fibrosis in deoxycorticosterone\/salt-treated rats","volume":"145","author":"Young","year":"2004","journal-title":"Endocrinology"},{"key":"10.1038\/ki.2012.170_bb0105","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1139\/y05-068","article-title":"Role of aldosterone in angiotensin II-induced cardiac and aortic inflammation, fibrosis, and hypertrophy","volume":"83","author":"Neves","year":"2005","journal-title":"Can J Physiol Pharmacol"},{"key":"10.1038\/ki.2012.170_bb0110","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1161\/01.HYP.0000203732.03784.3b","article-title":"Mineralocorticoid receptors and cardiovascular damage: it's not just aldosterone","volume":"47","author":"Funder","year":"2006","journal-title":"Hypertension"},{"key":"10.1038\/ki.2012.170_bb0115","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1097\/HJH.0b013e328300a232","article-title":"Paradoxical mineralocorticoid receptor activation and left ventricular diastolic dysfunction under high oxidative stress conditions","volume":"26","author":"Wang","year":"2008","journal-title":"J Hypertens"},{"key":"10.1038\/ki.2012.170_bb0120","doi-asserted-by":"crossref","first-page":"2171","DOI":"10.1093\/eurheartj\/ehn277","article-title":"Aldosterone synthase inhibition improves cardiovascular function and structure in rats with heart failure: a comparison with spironolactone","volume":"29","author":"Mulder","year":"2008","journal-title":"Eur Heart J"},{"key":"10.1038\/ki.2012.170_bb0125","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1161\/01.HYP.0000128621.68160.dd","article-title":"Role of osteopontin in cardiac fibrosis and remodeling in angiotensin II-induced cardiac hypertrophy","volume":"43","author":"Matsui","year":"2004","journal-title":"Hypertension"},{"key":"10.1038\/ki.2012.170_bb0130","doi-asserted-by":"crossref","first-page":"3871","DOI":"10.1210\/endo.141.10.7711","article-title":"Aldosterone: a mediator of myocardial necrosis and renal arteriopathy","volume":"141","author":"Rocha","year":"2000","journal-title":"Endocrinology"},{"key":"10.1038\/ki.2012.170_bb0135","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1113\/expphysiol.2009.048900","article-title":"Aldosterone synthesis in the brain contributes to Dahl salt-sensitive rat hypertension","volume":"95","author":"Gomez-Sanchez","year":"2010","journal-title":"Exp Physiol"},{"key":"10.1038\/ki.2012.170_bb0140","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1038\/nm.1879","article-title":"Modification of mineralocorticoid receptor function by Rac1 GTPase: implication in proteinuric kidney disease","volume":"14","author":"Shibata","year":"2008","journal-title":"Nat Med"},{"key":"10.1038\/ki.2012.170_bb0145","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1161\/HYPERTENSIONAHA.109.149062","article-title":"Mineralocorticoid receptors, salt-sensitive hypertension, and metabolic syndrome","volume":"55","author":"Fujita","year":"2010","journal-title":"Hypertension"},{"key":"10.1038\/ki.2012.170_bb0150","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.mce.2009.02.005","article-title":"New aspects of rapid aldosterone signaling","volume":"308","author":"Grossmann","year":"2009","journal-title":"Mol Cell Endocrinol"},{"key":"10.1038\/ki.2012.170_bb0155","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1097\/HJH.0b013e32834103a9","article-title":"Effects of mineralocorticoid receptor blockade on glucocorticoid-induced renal injury in adrenalectomized rats","volume":"29","author":"Rafiq","year":"2011","journal-title":"J Hypertens"},{"key":"10.1038\/ki.2012.170_bb0160","doi-asserted-by":"crossref","first-page":"F1178","DOI":"10.1152\/ajprenal.00532.2009","article-title":"Direct fibrogenic effects of aldosterone on normotensive kidney: an effect modified by 11\u03b2-HSD activity","volume":"298","author":"Brem","year":"2010","journal-title":"Am J Physiol Renal Physiol"},{"key":"10.1038\/ki.2012.170_bb0165","doi-asserted-by":"crossref","first-page":"F1381","DOI":"10.1152\/ajprenal.00101.2009","article-title":"Activation of local aldosterone system within podocytes is involved in apoptosis under diabetic conditions","volume":"297","author":"Lee","year":"2009","journal-title":"Am J Physiol Renal Physiol"},{"key":"10.1038\/ki.2012.170_bb0170","doi-asserted-by":"crossref","first-page":"2296","DOI":"10.1681\/ASN.2005020129","article-title":"Aldosterone stimulates proliferation of mesangial cells by activating mitogen-activated protein kinase 1\/2, cyclin D1, and cyclin A","volume":"16","author":"Terada","year":"2005","journal-title":"J Am Soc Nephrol"},{"key":"10.1038\/ki.2012.170_bb0175","first-page":"834","article-title":"Cross-talk between aldosterone and angiotensin signaling in vascular smooth muscle cells","volume":"76","author":"Rautureau","year":"2011","journal-title":"Steroids"},{"key":"10.1038\/ki.2012.170_bb0180","series-title":"Kidney Int Suppl","first-page":"S57","article-title":"The role of renin-angiotensin-aldosterone system in the progression of chronic kidney disease","author":"Remuzzi","year":"2005"},{"key":"10.1038\/ki.2012.170_bb0185","doi-asserted-by":"crossref","first-page":"2999","DOI":"10.1681\/ASN.2006050503","article-title":"Plasminogen activator inhibitor-1 in chronic kidney disease: evidence and mechanisms of action","volume":"17","author":"Eddy","year":"2006","journal-title":"J Am Soc Nephrol"},{"key":"10.1038\/ki.2012.170_bb0190","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1161\/01.HYP.35.1.150","article-title":"Implications of species difference for clinical investigation: studies on the renin-angiotensin system","volume":"35","author":"Hollenberg","year":"2000","journal-title":"Hypertension"},{"key":"10.1038\/ki.2012.170_bb0195","doi-asserted-by":"crossref","first-page":"2650","DOI":"10.1210\/en.2004-1102","article-title":"Homeostatic responses in the adrenal cortex to the absence of aldosterone in mice","volume":"146","author":"Lee","year":"2005","journal-title":"Endocrinology"},{"key":"10.1038\/ki.2012.170_bb0200","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1161\/01.ATV.0000152356.85791.52","article-title":"Pharmacological inhibition and genetic deficiency of plasminogen activator inhibitor-1 attenuates angiotensin II\/salt-induced aortic remodeling","volume":"25","author":"Weisberg","year":"2005","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1038\/ki.2012.170_bb0205","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1161\/01.HYP.37.2.801","article-title":"Aldosterone receptor antagonism normalizes vascular function in liquorice-induced hypertension","volume":"37","author":"Quaschning","year":"2001","journal-title":"Hypertension"},{"key":"10.1038\/ki.2012.170_bb0210","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1038\/sj.ki.5000201","article-title":"Plasminogen activator inhibitor-1 deficiency protects against aldosterone-induced glomerular injury","volume":"69","author":"Ma","year":"2006","journal-title":"Kidney Int"},{"key":"10.1038\/ki.2012.170_bb0215","doi-asserted-by":"crossref","first-page":"1959","DOI":"10.1111\/j.1523-1755.2004.00600.x","article-title":"Utility of endogenous creatinine clearance as a measure of renal function in mice","volume":"65","author":"Dunn","year":"2004","journal-title":"Kidney Int"},{"key":"10.1038\/ki.2012.170_bb0220","doi-asserted-by":"crossref","first-page":"25","DOI":"10.2144\/000112517","article-title":"ImageJ for microscopy","volume":"43","author":"Collins","year":"2007","journal-title":"Biotechniques"},{"key":"10.1038\/ki.2012.170_bb0225","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1006\/meth.2001.1262","article-title":"Analysis of relative gene expression data using real-time quantitative PCR and the 2\u2212\u0394\u0394CT method","volume":"25","author":"Livak","year":"2001","journal-title":"Methods"},{"key":"10.1038\/ki.2012.170_bb0230","series-title":"A Language and Environment for Statistical Computing","author":"R Development Core Team","year":"2010"}],"container-title":["Kidney International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0085253815556093?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0085253815556093?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,6,28]],"date-time":"2019-06-28T21:35:25Z","timestamp":1561757725000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0085253815556093"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,9]]},"references-count":45,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2012,9]]}},"alternative-id":["S0085253815556093"],"URL":"https:\/\/doi.org\/10.1038\/ki.2012.170","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.717956853.793461403","asserted-by":"object"}]},"ISSN":["0085-2538"],"issn-type":[{"value":"0085-2538","type":"print"}],"subject":[],"published":{"date-parts":[[2012,9]]}}}